NIVF NEWGENIVF GROUP LIMITED

NewGen Filed 2024 Annual Report on Form 20-F

NewGen Filed 2024 Annual Report on Form 20-F

BANGKOK, April 22, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 22, 2025 Eastern Time. The annual report can be accessed on the Company’s investor relations website at .

Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, “With $2.48 million cash with bank and a cash deposit of $1 million with a trading platform company, significantly exceeding our current market capitalization of $1.48 million, we believe we are currently in a healthy liquidity situation. We've successfully strengthened our balance sheet by settling all outstanding promissory notes and converting several mandatory additional notes into equity. With access to our $100 million equity line of credit facility, of which approximately $7.1 million has been drawn to date, we remain well-positioned to pursue strategic opportunities in this dynamic market environment.”

About NewGen

NewGen is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. With a mission to aid couples and individuals in building families regardless of fertility challenges, NewGen has dedicated itself to creating increased access to infertility treatment and providing comprehensive fertility services for its customers. NewGen’s management team collectively has over a decade of experience in the fertility industry. NewGen’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions, respectively. To learn more, visit . The information contained on, or accessible through, NewGen’s website is not incorporated by reference into this press release, and you should not consider it a part of this press release.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company’s future commercial operations, investments, business strategy, and financial condition. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company’s ability to access financing or draw down on the equity line of credit, changes in market conditions, or other factors beyond the Company’s control. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Company’s annual report on Form 20-F and other documents filed or to be filed by the Company with the SEC from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC’s website, All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contact

ICR, LLC

Robin Yang

Phone: +1 (212) 537-4406

Email:



EN
22/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NEWGENIVF GROUP LIMITED

 PRESS RELEASE

NewGenIVF Introduces NewGenSort to Support Men’s Reproductive Health A...

NewGenIVF Introduces NewGenSort to Support Men’s Reproductive Health Across Asia MicroSort® has been rebranded as NewGenSort as the technology becomes a more integral part of NewGen’s product offerings BANGKOK, May 07, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on the integration of its recently acquired MicroSort® technology. The strategic integration of this technology – which the company ...

 PRESS RELEASE

NewGenIVF Announces Reverse Stock Split

NewGenIVF Announces Reverse Stock Split BANGKOK, May 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it is implementing a reverse stock split of all of the Company's issued and unissued shares at an exchange ratio of one (1) share for ten (10) shares (the “Reverse Stock Split”). The Company’s Class A Ordinary Shares will begin trading on the Nasdaq Global Market on a post-Reverse Stock Split basis ...

 PRESS RELEASE

NewGen Filed 2024 Annual Report on Form 20-F

NewGen Filed 2024 Annual Report on Form 20-F BANGKOK, April 22, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 22, 2025 Eastern Time. The annual report can be accessed on the Company’s investor relations website at . Mr. Siu Wing Fung Alfred, Founder, Chairman,...

 PRESS RELEASE

NewGen Secures Strategic Funding to Drive International Expansion and ...

NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth Initial focus includes NewGen’s expansion into UAE, with further growth initiatives to follow BANGKOK, April 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has secured $5.2 million in strategic funding through two separate arrangements with an investor (“the investor”), with the potential to raise a total of...

 PRESS RELEASE

NewGenIVF Announces Termination of Proposed Reverse Merger Transaction...

NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness BANGKOK, March 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has terminated the binding term sheet with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) regarding their previously announced reverse merger transaction. On December 11, 2024, the Company announced its entry in...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch